Showing results (41-50 of 451) with videos related to

Sort By:
Pageof 46
Journal of Crohn'S & Colitis|October 6, 2017
Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing ColectomyMarc Ferrante, Anthony de Buck van Overstraeten, Nikkie Schils, et al.
Journal of Crohn'S & Colitis|October 14, 2017
Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel DiseaseWiebe Vanhove, Kris Nys, Ingrid Arijs, et al.
Acta Gastro-Enterologica Belgica|March 9, 2007
Protein-losing enteropathy in Crohn's diseaseMarc Ferrante, Freddy Penninckx, Gert De Hertogh, et al.
Inflammatory Bowel Diseases|November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over TimeSumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
The American Journal of Gastroenterology|March 17, 2011
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort studyChristine Breynaert, Marc Ferrante, Herma Fidder, et al.
Inflammatory Bowel Diseases|November 2, 2007
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitisMarc Ferrante, Sarah Declerck, Gert De Hertogh, et al.
Inflammatory Bowel Diseases|March 23, 2013
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitisBart Lemmens, Ingrid Arijs, Gert Van Assche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2017
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of InfliximabLieven Pouillon, Marc Ferrante, Gert Van Assche, et al.
Pageof 46